---
schema_version: "secwatch.filing_event.v1"
accession: "0001815776-26-000046"
form_type: "8-K"
ticker: "LENZ"
cik: "0001815776"
company_name: "LENZ Therapeutics, Inc."
filed_at: "2026-07-02T21:00:28+00:00"
generated_at: "2026-07-02T21:02:33.671742+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Zach Scheiner resigns from LENZ Therapeutics board; Jeff George appointed to audit committee

## Summary
- Zach Scheiner resigned from the Board and all committees effective June 30, 2026.
- Resignation was not due to any dispute or disagreement with the company.
- Board size reduced from seven to six members following the resignation.
- Jeff George appointed to Audit Committee; members now Thunen, Guerard, and George.

## SEC filing metadata
- accession: 0001815776-26-000046
- form_type: 8-K
- ticker: LENZ
- cik: 0001815776
- company_name: LENZ Therapeutics, Inc.
- filed_at: 2026-07-02T21:00:28+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000046/0001815776-26-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000046/lenz-20260630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001815776-26-000046
- JSON: https://secwatch.observer/filing/0001815776-26-000046.json
- Plain text: https://secwatch.observer/filing/0001815776-26-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.